Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Frères

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Case Reports in Oncology|July 16, 2021
Cemiplimab for Cisplatin Resistant Metastatic Penile CancerChloé Denis, Sarah Sakalihasan, Pierre Frères, et al.
Revue Medicale De Liege|June 8, 2026
[How can we address carcinogenic environmental and behavioural factors ?]Sarah Saglime, Pierre Frères, Brieuc Sautois, et al.
Revue Medicale De Liege|June 16, 2025
[Recommendations for the management of kidney cancer in 2025]Manon Wick, Chloé Denis, Pierre Frères, et al.
Oncotarget|September 29, 2018
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatmentConcetta Elisa Onesti, Claire Josse, Aurélie Poncin, et al.
Revue Medicale De Liege|September 11, 2025
[PARP inhibitors (poly-ADP-ribose polymerase) : newcomers in the management of prostate cancers]Émeline Petit, Guy Jerusalem, Chloé Denis, et al.
Journal of Cellular Physiology|August 1, 2014
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 ExpressionPierre Frères, Claire Josse, Nicolas Bovy, et al.
BMC Cancer|April 17, 2015
BRCA1 germline mutation and glioblastoma development: report of casesMeriem Boukerroucha, Claire Josse, Karin Segers, et al.
Scientific Reports|June 4, 2021
Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sitesJeanne P Uyisenga, Ahmed Debit, Christophe Poulet, et al.
BMC Cancer|October 23, 2015
Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancersMeriem Boukerroucha, Claire Josse, Sonia ElGuendi, et al.
BMC Cancer|January 31, 2018
Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patientsPierre Frères, Nassim Bouznad, Laurence Servais, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Case Reports in Oncology|July 16, 2021
Cemiplimab for Cisplatin Resistant Metastatic Penile CancerChloé Denis, Sarah Sakalihasan, Pierre Frères, et al.
Revue Medicale De Liege|June 8, 2026
[How can we address carcinogenic environmental and behavioural factors ?]Sarah Saglime, Pierre Frères, Brieuc Sautois, et al.
Revue Medicale De Liege|June 16, 2025
[Recommendations for the management of kidney cancer in 2025]Manon Wick, Chloé Denis, Pierre Frères, et al.
Oncotarget|September 29, 2018
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatmentConcetta Elisa Onesti, Claire Josse, Aurélie Poncin, et al.
Revue Medicale De Liege|September 11, 2025
[PARP inhibitors (poly-ADP-ribose polymerase) : newcomers in the management of prostate cancers]Émeline Petit, Guy Jerusalem, Chloé Denis, et al.
Journal of Cellular Physiology|August 1, 2014
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 ExpressionPierre Frères, Claire Josse, Nicolas Bovy, et al.
BMC Cancer|April 17, 2015
BRCA1 germline mutation and glioblastoma development: report of casesMeriem Boukerroucha, Claire Josse, Karin Segers, et al.
Scientific Reports|June 4, 2021
Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sitesJeanne P Uyisenga, Ahmed Debit, Christophe Poulet, et al.
BMC Cancer|October 23, 2015
Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancersMeriem Boukerroucha, Claire Josse, Sonia ElGuendi, et al.
BMC Cancer|January 31, 2018
Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patientsPierre Frères, Nassim Bouznad, Laurence Servais, et al.
Pageof 2